Novartis CEO Vas Narasimhan on The David Rubenstein Show

(24:7)

Novartis CEO Vas Narasimhan: Expect solid growth this year top and bottom line

(3:50)

Novartis CEO Joe Jimenez: The best advice I ever got

(37)

Novartis CEO discusses how AI will impact drug development

(6:51)

Novartis CEO on the impact of the U.S. election for pharma

(3:7)

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

(3:45)

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company

(25:17)

Reimagining Medicine with Data \u0026 Digital | Novartis CEO at #VivaTech19

(23:37)

Focus remains on R\u0026D to drive growth of blockbuster drugs, says Novartis CEO

(4:19)

Vasant Narasimhan Novartis CEO On Transforming Pharma Industry

(9:32)

Vasant Narasimhan Novartis CEO On Transforming Pharma Industry

(9:32)

South Asian Trailblazers: Vas Narasimhan (CEO of Novartis) and Srishti Gupta (Leader in Health \u0026 Ed)

(1:14:3)

Looking For A Better Owner For Our India-Listed Biz: Novartis CEO | Exclusive | Global Dialogues

(26:6)

Talking culture transformation with Vas Narasimhan and Adam Grant

(11:44)

M\u0026A, obesity top of mind for investors at J.P. Morgan Healthcare conference: Portal Innovations CEO

(5:27)

Vas Narasimhan at the 2019 One Young World Summit

(9:8)

Novartis CEO Believes in an 'Unbossed' Culture

(2:7)

Novartis CEO: Growth drivers performing well, but product exclusivity losses creating headwinds

(9:48)

AI, vaccine distrust, \u0026 the future of healthcare: Novartis CEO

(24:1econd)

Novartis expects 'strong momentum' going into second half, says CEO Vasant Narasimhan

(5:53)

Davos World Economic Forum LIVE | Vas Narasimhan Novartis CEO Exclusive | N18G | CNBC TV18

(9:25)

Leaders with Lacqua: Vasant Narasimhan, Novartis CEO

(24:6)

Cautiously Hopeful Of AI's Role In Drug Discovery: Novartis CEO Vas Narasimhan

(9:5)

A message about Managed Access from Vas Narasimhan CEO Novartis

(3:56)

Watch CNBC's full interview with Novartis CEO Vas Narasimhan

(7:51)

Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm

(1:15)

Novartis CEO on new cancer therapy programs

(4:22)

Novartis CEO: Expect continued growth in 2023

(6:12)

Novartis CEO on Acquisitions, AI, Weight-Loss Drugs

(4:19)